Carl Zeiss Meditec Cataract Technology Inc. – Trademark Portfolio

Entity Type: 03

Carl Zeiss Meditec Cataract Technology Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. Currently, 1 trademark is registered. Notable registered marks include MILOOP. The owner is based in Reno, NV.

8748 Technology Way

Reno, NV 89521

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MIKIT
MIKIT
Abandoned 2018
XPORT
XPORT
Abandoned 2018
MIKIT
MIKIT
Abandoned 2017
MILOOP
MILOOP
Registered 2016

Trademark Classifications

Carl Zeiss Meditec Cataract Technology Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Carl Zeiss Meditec Cataract Technology Inc. have?

Carl Zeiss Meditec Cataract Technology Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned.

What trademark classes does Carl Zeiss Meditec Cataract Technology Inc. file in?

Carl Zeiss Meditec Cataract Technology Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Carl Zeiss Meditec Cataract Technology Inc.'s most well-known trademarks?

Carl Zeiss Meditec Cataract Technology Inc.'s registered trademark portfolio includes well-known marks such as MILOOP. These are among 1 currently registered trademark in the portfolio.

What is Carl Zeiss Meditec Cataract Technology Inc.'s trademark registration success rate?

Carl Zeiss Meditec Cataract Technology Inc. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.